Page last updated: 2024-08-26

artenimol and physcione

artenimol has been researched along with physcione in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Arellano, ML; Boggon, TJ; Chen, J; Elf, S; Fan, J; Gaddh, M; Khoury, HJ; Khuri, FR; Lee, BH; Lin, R; Lonial, S; Pan, Y; Shan, C; Wu, S; Xia, S	1

Other Studies

1 other study(ies) available for artenimol and physcione

Article	Year
Targeting 6-phosphogluconate dehydrogenase in the oxidative PPP sensitizes leukemia cells to antimalarial agent dihydroartemisinin. Oncogene, 2017, 01-12, Volume: 36, Issue:2 Topics: Animals; Antimalarials; Antineoplastic Combined Chemotherapy Protocols; Artemisinins; Cell Line, Tumor; Cell Survival; Drug Synergism; Emodin; Female; Humans; K562 Cells; Leukemia; Mice; Mice, Nude; Pentose Phosphate Pathway; Phosphogluconate Dehydrogenase; Xenograft Model Antitumor Assays	2017

Article

Year

Targeting 6-phosphogluconate dehydrogenase in the oxidative PPP sensitizes leukemia cells to antimalarial agent dihydroartemisinin.

Oncogene, 2017, 01-12, Volume: 36, Issue:2

Topics: Animals; Antimalarials; Antineoplastic Combined Chemotherapy Protocols; Artemisinins; Cell Line, Tumor; Cell Survival; Drug Synergism; Emodin; Female; Humans; K562 Cells; Leukemia; Mice; Mice, Nude; Pentose Phosphate Pathway; Phosphogluconate Dehydrogenase; Xenograft Model Antitumor Assays

2017